Relypsa, Inc. (RLYP) Adds Industry Veterans Daniel K. Spiegelman And Kenneth J. Hillan To Its Board Of Directors
6/20/2014 8:33:05 AM
REDWOOD CITY, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP), a biopharmaceutical company, today announced the election of Daniel K. Spiegelman, executive vice president and chief financial officer of BioMarin Pharmaceutical Inc., and Kenneth J. Hillan, president and chief executive officer of Achaogen, Inc., to its board of directors following the company's annual meeting of stockholders held earlier today. Mr. Spiegelman and Dr. Hillan are well established biopharmaceutical executives with expertise in managing public companies through research and development to international commercial operations.
Help employers find you! Check out all the jobs and post your resume.
comments powered by